ANI Pharmaceuticals Investor Relations Material
Latest events
Q2 2024
ANI Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from ANI Pharmaceuticals Inc
Access all reports
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops and markets proprietary pharmaceutical products in the United States and Canada. The company manufactures and distributes branded, generic, and specialty products. It markets its product in various dosage forms to hospitals; long-term care facilities; home care settings; physicians' offices; pharmacies; retail chains and independent drugstores; managed care organizations; government programs; and other physician groups. The company also provides a full range of services related to the development of pharmaceutical products, including expertise in chemistry, manufacturing, quality control/research & development, regulatory affairs/health economics/clinical studies/medical writing, clinical phase drug development.
Key slides for ANI Pharmaceuticals Inc
M&A Announcement
ANI Pharmaceuticals Inc
M&A Announcement
ANI Pharmaceuticals Inc
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
ANIP
Country
🇺🇸 United States